SERENA BROUELETTE: Open Payments
NPI 1083486187 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$918 in 37 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $763 · 2025 $918
Food & beverage: $918
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 11 | $207 |
| Arcutis Biotherapeutics, Inc. | 4 | $140 |
| ABBVIE INC. | 6 | $116 |
| GENZYME CORPORATION | 3 | $105 |
| Biofrontera Inc. | 4 | $88 |
| LEO Pharma Inc. | 2 | $83 |
| Galderma Laboratories, L.P. | 1 | $48 |
| Lilly USA, LLC | 1 | $27 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $24 |
| Botanix SB Inc | 1 | $24 |
Products named: OPZELURA, Zoryve, DUPIXENT, ANZUPGO, SKYRIZI, EBGLYSS, Cabtreo, SOFDRA.
Industry payments across CA — which companies pay providers there.
